Susan L. Hogan, PhD, MPH; Ronald J. Falk, MD; Hyunsook Chin, MPH; Jianwen Cai, PhD; Caroline E. Jennette, MSW; J. Charles Jennette, MD; Patrick H. Nachman, MD
The authors aimed to identify predictors of relapse and resistance to treatment in 350 patients with antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis. Patients had Wegener granulomatosis, microscopic polyangiitis, and vasculitis confined to the kidney. Treatment resistance was associated with female sex, black ethnicity, and severe kidney disease at presentation. Relapse was associated with antiproteinase-3 antibodies and disease of the lung or upper respiratory tract.
Ann Intern Med. 2005;143(9):621-631. doi:10.7326/0003-4819-143-9-200511010-00005
Régis Sablé-Fourtassou, MD; Pascal Cohen, MD; Alfred Mahr, MD; Christian Pagnoux, MD; Luc Mouthon, MD, PhD; David Jayne, MD; Daniel Blockmans, MD, PhD; Jean-François Cordier, MD; Philippe Delaval, MD; Xavier Puechal, MD, PhD; Dominique Lauque, MD; Jean-François Viallard, MD, PhD; Abdelkader Zoulim, MD; Loïc Guillevin, MD; and the French Vasculitis Study Group*
Of 112 patients with a new diagnosis of the Churg–Strauss syndrome, 43 (38%) were positive for antineutrophil cytoplasmic antibody (ANCA). Positive ANCA status was associated with renal involvement, peripheral neuropathy, and biopsy-proven vasculitis. Negative ANCA status was associated with heart disease and fever. The presenting clinical features of the Churg–Strauss syndrome appear to be related to ANCA status.
Ann Intern Med. 2005;143(9):632-638. doi:10.7326/0003-4819-143-9-200511010-00006
Kirsten K. Ness, PhD; Ann C. Mertens, PhD; Melissa M. Hudson, MD; Melanie M. Wall, PhD; Wendy M. Leisenring, PhD; Kevin C. Oeffinger, MD; Charles A. Sklar, MD; Leslie L. Robison, PhD; James G. Gurney, PhD
This study compared 11 481 long-term survivors of childhood cancer with 3839 unaffected siblings. Survivors were more likely to report limitations on performance, including personal care skills and attendance at work or school. Survivors of brain and bone cancer were most at risk.
Ann Intern Med. 2005;143(9):639-647. doi:10.7326/0003-4819-143-9-200511010-00007
Barna D. Tugwell, MD; Priti R. Patel, MD, MPH; Ian T. Williams, PhD, MS; Katrina Hedberg, MD, MPH; Feng Chai, PhD; Omana V. Nainan, PhD; Ann R. Thomas, MD, MPH; Judith E. Woll, MD; Beth P. Bell, MD, MPH; Paul R. Cieslak, MD
The authors used molecular techniques to prove that an organ and tissue donor who was negative for antibody to hepatitis C virus (HCV) transmitted HCV infection to 8 transplant recipients. Although this occurrence is probably uncommon, it may provoke discussion of the value of testing potential transplant donors for HCV RNA.
Ann Intern Med. 2005;143(9):648-654. doi:10.7326/0003-4819-143-9-200511010-00008
Charles F. von Gunten, MD, PhD; True Ryndes, ANP, MPH
Hospice has 3 forms in the United States. Traditional hospice provides palliative care for the dying. Community hospice provides multifaceted programs, including palliative care, for patients with eventually fatal disease. Academic hospice has a more complex mission that includes patient care, public health, and education and research.
Ann Intern Med. 2005;143(9):655-658. doi:10.7326/0003-4819-143-9-200511010-00009
Alexander M. Clark, PhD, BA, RN; Lisa Hartling, MSc; Ben Vandermeer, BSc, MSc; Finlay A. McAlister, MD, MSc
The authors reviewed 63 randomized trials that measured the effect of adding an exercise program to secondary cardiac prevention programs. Programs that promoted exercise reduced all-cause mortality (summary risk ratio, 0.85 [95% CI, 0.77 to 0.94]) relative to programs that did not promote exercise. Exercise-promoting programs had no added benefit 1 year after patients began them but reduced mortality substantially after 2 years.
Ann Intern Med. 2005;143(9):659-672. doi:10.7326/0003-4819-143-9-200511010-00010
Leonard Wartofsky, MD
This Update is a critical examination of articles selected from more than 25 peer-reviewed journals from the fields of endocrinology and general internal medicine. The importance of the observations and their applicability to clinical practice were the criteria for selecting articles. The topics include diabetes mellitus, thyroid disease, lipid-lowering therapy, and adrenal function.
Ann Intern Med. 2005;143(9):673-682. doi:10.7326/0003-4819-143-9-200511010-00011
Gary S. Hoffman, MD, MS; Carol A. Langford, MD, MHS
For some autoimmune diseases, autoantibodies and their target antigen specificity can provide information about pathogenic mechanisms and disease phenotypes. What do antineutrophil cytoplasmic antibodies (ANCAs) tell us about a patient with vasculitis? Do ANCAs or their antigen specificity identify patients whose vasculitis differs in its clinical expression and relapse potential? If so, could this information guide treatment? Two articles in this issue address these questions.
Ann Intern Med. 2005;143(9):683-685. doi:10.7326/0003-4819-143-9-200511010-00012
Y. Pritham Raj, MD
Transitional objects are ubiquitous in childhood. They may take the form of a favorite blanket or, in my 18-month-old son's case, a stuffed bear named Bo. Mine was, oddly enough, a label maker. Once I could spell, the “click, click-click” of the label maker became standard household din. Upon matriculation to medical school, I was introduced to a new, more sophisticated form of labeling. More rooted in science than in the imagination, it was the art of creating medical diagnostic labels.
Ann Intern Med. 2005;143(9):686-687. doi:10.7326/0003-4819-143-9-200511010-00013
Alex Zusman, MD, MPH
I am writing to apologize for all the confusion and to explain what has happened to you. I believe you did not receive the best care possible, and I would have expected more for my grandparent. There is more information regarding that clot in your left leg. You might justifiably ask, “Why was I initially told that the clot had disappeared only to find out, after leaving the hospital in good faith, that it was still there?” You are probably pondering this question on your way to have a filter placed in one of your large blood vessels.
Ann Intern Med. 2005;143(9):688-689. doi:10.7326/0003-4819-143-9-200511010-00014
Ann Intern Med. 2005;143(9):690. doi:10.7326/0003-4819-143-9-200511010-00015
Ann Intern Med. 2005;143(9):690-691. doi:10.7326/0003-4819-143-9-200511010-00016
Ann Intern Med. 2005;143(9):691. doi:10.7326/0003-4819-143-9-200511010-00017
Ann Intern Med. 2005;143(9):691. doi:10.7326/0003-4819-143-9-200511010-00018
Ann Intern Med. 2005;143(9):691-692. doi:10.7326/0003-4819-143-9-200511010-00019
Ann Intern Med. 2005;143(9):692-693. doi:10.7326/0003-4819-143-9-200511010-00020
Ann Intern Med. 2005;143(9):693. doi:10.7326/0003-4819-143-9-200511010-00021
Ann Intern Med. 2005;143(9):693. doi:10.7326/0003-4819-143-9-200511010-00022
Ann Intern Med. 2005;143(9):694-695. doi:10.7326/0003-4819-143-9-200511010-00023
Ann Intern Med. 2005;143(9):695. doi:10.7326/0003-4819-143-9-200511010-00024
Ann Intern Med. 2005;143(9):695. doi:10.7326/0003-4819-143-9-200511010-00025
Davey Smith, MD
Ann Intern Med. 2005;143(9):682. doi:10.7326/0003-4819-143-9-200511010-00028
Ann Intern Med. 2005;143(9):I-22. doi:10.7326/0003-4819-143-9-200511010-00001
Ann Intern Med. 2005;143(9):I-30. doi:10.7326/0003-4819-143-9-200511010-00002
Ann Intern Med. 2005;143(9):I-86. doi:10.7326/0003-4819-143-9-200511010-00003
Ann Intern Med. 2005;143(9):I-87. doi:10.7326/0003-4819-143-9-200511010-00004
Karen J. Sherman, PhD, MPH
Ann Intern Med. 2005;143(9):696. doi:10.7326/0003-4819-143-9-200511010-00026
Edgar R. Miller III, MD, PhD
Ann Intern Med. 2005;143(9):696. doi:10.7326/0003-4819-143-9-200511010-00027
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only